Please wait…

Login required

Username or email:
Password:

To use this function please log-in
If you haven't got an account on boerse-frankfurt.de, you have the opportunity to register regist here for free.

add instrument

Amundi Healthcare Stock (A)

Amundi Healthcare Stock (A)


ISIN AT0000754270 | WKN 937539 | Mnemonic FHDS | Type fund
21/05/2019 15:32
Bid Ask
This product is subject to quotation restrictions.
18.1400
18.4000
for
552
units
for
544
units
Change from Prev. Day 0.10 EUR / 0.55%
Spread absolute / relative 0,26 / 1,43%

Net Asset Value

Previous Day 18.04 EUR Date 17/05/2019

Price Information

Last Price 18.1700
Date / Time 21.05.2019 / 15:32:49
Price -
Volume in euro -
Volume Size -
High 18.170
Low 18.110
52 week High 19.200
52 week Low 16.800
Trading Hours 09:00 - 18:00

Price History

Date Opening Price Closing Price Daily High Daily Low Volume (pcs.)
20/05/2019 18.0800 18.0700 18.0800 18.0700
17/05/2019 18.0700 18.1200 18.1200 18.0500
16/05/2019 17.8600 17.8800 17.8800 17.8600
15/05/2019 17.8200 17.8600 17.8600 17.8100
14/05/2019 17.8000 17.8100 17.8100 17.8000

Fees

Management Fee 1.50 %
Custodian Fee 0.10 %
Capital forming savings possible? no
Savings Plan no
Distribution Distributring

Frankfurt Trading Parameters

Specialist ICF BANK AG WERTPAPIERHANDELSB. WG FONDS
Continous Quotation no
Minimum tradeable Unit 1

Rating for Amundi Healthcare Stock (A)

€uro FondsNote 3
Lipper Leaders, 3 years -
Lipper Leaders, 5 years -
Lipper Leaders, 10 years -
Lipper Leaders, overall -

Advertisement

Fundamental Data

WKN 937539
ISIN AT0000754270
Name Amundi Healthcare Stock (A)
Investment Company Amundi (A)
Issued in Österreich
Issue Date 01/03/2000
Category Aktienfonds Pharma + Gesundheit
currency EUR
Volume 59,272,602.00
Depositary Bank UniCredit Bank Austria
Paying Agent WestLB
Fund Management Capital Invest Team
Fiscal Year-End 28.02.
Last Update 28/01/2019

Investment policy

invest like Amundi Healthcare Stock (A): Anlageziel ist ein langfristiger Kapitalzuwachs. Der Fonds investiert sowohl über Anteile an anderen Investmentfonds als auch über Direktanlagen mindestens 51% des Fondsvermögens in Aktien und Aktien gleichwertige Wertpapiere der Branchen Pharma und Biotechnologie. Daneben kann der Fonds in Anteile an anderen Investmentfonds mit dem Anlageschwerpunkt Aktien und Aktien gleichwertige Wertpapiere des Gesundheitswesens (Healthcare) investieren.

The following Disclaimer and Information has been prepared by Voltabox AG (the “Issuer”) for the purpose of publishing THE securities prospectus by the issuer. Deutsche Boerse AG does not assume any responsibility for the content of the issuer`s Disclaimer and information.

 

Important Information


 

The information contained on the following web pages is directed only at persons who are resident of or domiciled in the Federal Republic of Germany (“Germany”) or the Grand Duchy of Luxembourg (“Luxembourg”). The following information does not constitute an offer to sell or a solicitation of an offer to buy or subscribe for any securities. No offer of securities of the Issuer is being, or will be, made to the public outside Germany and Luxembourg. The offer in Germany and Luxembourg is being made solely on the basis of the securities prospectus (including any amendments thereto) which has been approved by the German Bundesanstalt für Finanzdienstleistungsaufsicht (BaFin) and which has been published on the Issuer’s website. Any investment decision regarding the publicly offered securities of the Issuer should only be made on the basis of the securities prospectus. The securities prospectus is available free of charge from the Issuer (Artegastraße 1, 33129 Delbrück, Germany; Tel.: +49 (0)5250 9930-900; Fax: +49 (0)5250 9762-102) and on the Issuer’s website (www.voltabox.ag).



The information contained on the following web pages is not an offer of securities for sale or a solicitation of an offer to purchase securities in the United States of America (“United States”), Canada, Australia or Japan. The Issuer’s shares, and the securities offered in the course of the offer, have not been and will not be registered under the US Securities Act of 1933, as amended (“Securities Act”), or with any other securities regulatory authority of any state or other jurisdiction of the United States and may not be offered, sold or delivered within the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and applicable state securities laws. The Issuer does not intend to register the offer or parts thereof in the United States or make an offer to the public in the United States, Canada, Australia or Japan.



The information contained on the following web pages is not for distribution to persons who are located in the United States, Canada, Australia or Japan or any other jurisdiction where the offer of the securities to the public is not taking place. Any violation of these restrictions may constitute a breach of the securities laws of these countries. The copying, forwarding or other transmission of the content of the following web pages is prohibited.

By clicking the "I AGREE" button below, you warrant that (i) you have read and accepted the foregoing information and restrictions in full and (ii) you are a resident of or domiciled in Germany or Luxembourg, and (iii) you agree not to distribute or forward the information contained on the following web pages to any person who is not a resident of or domiciled in Germany or Luxembourg.

 


We regret that, due to regulatory restrictions, we are unable to provide you with access to the following web pages.